We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMT
3026
Aberdeen Multi-Market Income Fund
MMT
$244M
$403K ﹤0.01%
89,306
+18,657
+26% +$82K
IDE
3027
Voya Infrastructure, Industrials and Materials Fund
IDE
$201M
$403K ﹤0.01%
43,893
-2,011
-4% -$18.6K
PTLO icon
3028
Portillo's
PTLO
$365M
$402K ﹤0.01%
24,651
-3,033
-11% -$60.7K
GLP icon
3029
Global Partners
GLP
$1.69B
$402K ﹤0.01%
11,570
-2,248
-16% -$69.4K
ENS icon
3030
EnerSys
ENS
$7.2B
$402K ﹤0.01%
5,440
+3
+0.1% +$209
FFWM
3031
DELISTED
First Foundation Inc
FFWM
$401K ﹤0.01%
28,001
-4,027
-13% -$62.4K
SPTN
3032
DELISTED
SpartanNash
SPTN
$401K ﹤0.01%
13,268
-2,767
-17% -$90.1K
GAIN icon
3033
Gladstone Investment Corp
GAIN
$658M
$401K ﹤0.01%
31,030
+1,198
+4% +$15.8K
RIV
3034
RiverNorth Opportunities Fund
RIV
$308M
$400K ﹤0.01%
32,555
+7,987
+33% +$99.3K
FTXH icon
3035
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$965M
$400K ﹤0.01%
14,573
-110,452
-88% -$2.94M
ONEW icon
3036
OneWater Marine
ONEW
$203M
$400K ﹤0.01%
13,975
-1,825
-12% -$57K
NUS icon
3037
Nu Skin
NUS
$236M
$399K ﹤0.01%
9,463
-5,400
-36% -$208K
EWG icon
3038
iShares MSCI Germany ETF
EWG
$1.67B
$398K ﹤0.01%
16,108
+2,650
+20% +$61.8K
YPF icon
3039
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
$397K ﹤0.01%
43,227
+25,888
+149% +$200K
FBNC icon
3040
First Bancorp
FBNC
$2.74B
$397K ﹤0.01%
9,267
-16
-0.2% -$701
FMAT icon
3041
Fidelity MSCI Materials Index ETF
FMAT
$610M
$396K ﹤0.01%
9,083
-91
-1% -$3.92K
CVY icon
3042
Invesco Zacks Multi-Asset Income ETF
CVY
$125M
$396K ﹤0.01%
18,730
-5,388
-22% -$116K
SFL icon
3043
SFL Corp
SFL
$1.61B
$396K ﹤0.01%
42,958
-10,674
-20% -$104K
BATT icon
3044
Amplify Lithium & Battery Technology ETF
BATT
$124M
$396K ﹤0.01%
33,803
-31,161
-48% -$404K
LRN icon
3045
Stride
LRN
$3.48B
$396K ﹤0.01%
12,648
-4,234
-25% -$155K
PFS icon
3046
Provident Financial Services
PFS
$3.26B
$395K ﹤0.01%
18,500
REM icon
3047
iShares Mortgage Real Estate ETF
REM
$547M
$395K ﹤0.01%
17,405
-14,910
-46% -$347K
RNST icon
3048
Renasant Corp
RNST
$4B
$394K ﹤0.01%
10,485
-8,374
-44% -$317K
MAN icon
3049
ManpowerGroup
MAN
$2.75B
$392K ﹤0.01%
4,715
+26
+0.6% +$2.09K
LXP icon
3050
LXP Industrial Trust
LXP
$3.58B
$391K ﹤0.01%
7,808
-32
-0.4% -$1.6K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.